These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
185 related articles for article (PubMed ID: 35501858)
1. Involvement of IL-26 in bronchiolitis obliterans syndrome but not in acute rejection after lung transplantation. Magnusson JM; Ericson P; Tengvall S; Stockfelt M; Brundin B; Lindén A; Riise GC Respir Res; 2022 May; 23(1):108. PubMed ID: 35501858 [TBL] [Abstract][Full Text] [Related]
2. Comparison of induced sputum and bronchoalveolar lavage in lung transplant recipients. Mamessier E; Milhe F; Badier M; Thomas P; Magnan A; Reynaud-Gaubert M J Heart Lung Transplant; 2006 May; 25(5):523-32. PubMed ID: 16678030 [TBL] [Abstract][Full Text] [Related]
3. Persistent high BAL fluid granulocyte activation marker levels as early indicators of bronchiolitis obliterans after lung transplant. Riise GC; Andersson BA; Kjellström C; Martensson G; Nilsson FN; Ryd W; Scherstén H Eur Respir J; 1999 Nov; 14(5):1123-30. PubMed ID: 10596701 [TBL] [Abstract][Full Text] [Related]
4. Airway neutrophilia in stable and bronchiolitis obliterans syndrome patients following lung transplantation. Zheng L; Walters EH; Ward C; Wang N; Orsida B; Whitford H; Williams TJ; Kotsimbos T; Snell GI Thorax; 2000 Jan; 55(1):53-9. PubMed ID: 10607802 [TBL] [Abstract][Full Text] [Related]
5. Decreased serum and bronchoalveolar lavage levels of Clara cell secretory protein (CC16) is associated with bronchiolitis obliterans syndrome and airway neutrophilia in lung transplant recipients. Nord M; Schubert K; Cassel TN; Andersson O; Riise GC Transplantation; 2002 Apr; 73(8):1264-9. PubMed ID: 11981419 [TBL] [Abstract][Full Text] [Related]
6. The presence of a matrix-derived neutrophil chemoattractant in bronchiolitis obliterans syndrome after lung transplantation. Hardison MT; Galin FS; Calderon CE; Djekic UV; Parker SB; Wille KM; Jackson PL; Oster RA; Young KR; Blalock JE; Gaggar A J Immunol; 2009 Apr; 182(7):4423-31. PubMed ID: 19299743 [TBL] [Abstract][Full Text] [Related]
7. Bronchiolitis obliterans syndrome in lung transplant recipients is associated with increased neutrophil activity and decreased antioxidant status in the lung. Riise GC; Williams A; Kjellström C; Schersten H; Andersson BA; Kelly FJ Eur Respir J; 1998 Jul; 12(1):82-8. PubMed ID: 9701419 [TBL] [Abstract][Full Text] [Related]
8. Aspiration, localized pulmonary inflammation, and predictors of early-onset bronchiolitis obliterans syndrome after lung transplantation. Fisichella PM; Davis CS; Lowery E; Ramirez L; Gamelli RL; Kovacs EJ J Am Coll Surg; 2013 Jul; 217(1):90-100; discussion 100-1. PubMed ID: 23628225 [TBL] [Abstract][Full Text] [Related]
9. Interleukin-1 receptor antagonist as a biomarker for bronchiolitis obliterans syndrome in lung transplant recipients. Belperio JA; DiGiovine B; Keane MP; Burdick MD; Ying Xue Y; Ross DJ; Lynch JP; Kunkel SL; Strieter RM Transplantation; 2002 Feb; 73(4):591-9. PubMed ID: 11889437 [TBL] [Abstract][Full Text] [Related]
10. Clinical utility of bronchoalveolar lavage cell phenotype analyses in the postoperative monitoring of lung transplant recipients. Reynaud-Gaubert M; Thomas P; Gregoire R; Badier M; Cau P; Sampol J; Giudicelli R; Fuentes P Eur J Cardiothorac Surg; 2002 Jan; 21(1):60-6. PubMed ID: 11788258 [TBL] [Abstract][Full Text] [Related]
11. Bronchoalveolar lavage fluid characteristics in acute and chronic lung transplant rejection. Slebos DJ; Postma DS; Koëter GH; Van Der Bij W; Boezen M; Kauffman HF J Heart Lung Transplant; 2004 May; 23(5):532-40. PubMed ID: 15135367 [TBL] [Abstract][Full Text] [Related]
12. Upregulation of chemokines in bronchoalveolar lavage fluid as a predictive marker of post-transplant airway obliteration. Reynaud-Gaubert M; Marin V; Thirion X; Farnarier C; Thomas P; Badier M; Bongrand P; Giudicelli R; Fuentes P J Heart Lung Transplant; 2002 Jul; 21(7):721-30. PubMed ID: 12100898 [TBL] [Abstract][Full Text] [Related]